Composition “Laennek”
- 1 cell growth factors (total 36):
- HGF (hepatocyte growth factor FRG)
- NGF (nerve growth factor NGF)
- EGF (epidermal growth factor EDF)
- FGF (FGF fibroblast growth factor)
- CSF (colony growth factor KGF)
- IGF (insulin-like growth factor IGF)
- TGF (transforming growth factor TGF)
- VEGF (VEGF vascular endothelial growth factor)
- Cytokines
- 2 Interleukins 1-6, 8, 10, 12
- 3 Erythropoietin
- 4 Interferon gamma
- Aminoacids, including essential (of 18)
- Peptides, nucleotides
- Peptid DNEA
- Glikozaminoglikany
- elements:Na, P, C, S, Na, Mg, Ca, K
- Essential and traces elements:Zn, Br, Si, Fe, Mn, Sc, Se, Cr, V, Cu, Li, B, Co
- Vitamines:B1, B2, B3, C, D, PP
- Enzymes
The low molecular weight active ingredients for optimum pharmacokinetics of the drug when it is administered intramuscularly. Injections of the drug “Laennec” well tolerated, virtually painless. The drug is hypoallergenic.
Indications:
- chronic liver disease;
- Atopic dermatitis (moderate and severe, complicated)
- recurrent herpes;
- drug, alcohol and environmental toxicity;
- fatigue;
- insomnia;
- decreased immunity;
- sexual dysfunction, and the common voltage;
- violation of the functions of the pelvic organs;
- reduction in the body’s defenses;
- deterioration of cerebral blood circulation, vision, hearing, memory;
Effect:
- Regeneration of liver cells;
- increased immunity;
- strengthen the body’s defenses;
- stress relief, insomnia, a common voltage;
- improvement of internal organs;
- ensuring uniform circulation of the blood;
- revitalization of all organs and systems of the body as a whole;
- improving brain blood circulation, vision, hearing, memory;
- activation function of the pelvic organs, elimination of sexual dysfunction;
- powerful lifting effect.
Recommended Dosage :
The dosage is usually set on a case-by-case basis according to the clinical picture and the patient’s general condition.
In general, at chronic diseases of a liver ( (fatty liver, fibrosis and cirrhosis) , the drug is injected on 2 ml/days (112 mg of a hydrolyzate of a placenta). Depending on disease severity the frequency of injections can be increased to 2-3 times (6 ml) / days. The drug can be injected in10 ml (560 mg of a hydrolyzate of a placenta) of a preparation (5 ampoules) dissolve in 250-500 ml 5% of solution of a dextrose or physiological solution and enter through an elbow vein during 1.5-2 h. Injections carry out 2 times a week for 2-3 weeks.
Overdose
Now about cases of overdose of a preparation Laennec it was not reported.
Read PDF files
Laennec fragments peptides – liver cirrhosis ttt
